Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Kraig Biocraft Laboratories Q3 2026 Results: Net Loss of $1.24M, Loss Narrows

Kraig Biocraft Laboratories reported a net loss of $3,095,751 for the nine months ended September 30, 2026, compared to a loss of $2,835,732 in the prior year period. The company generated minimal revenue of $3,000 during the quarter and continues to operate with a significant stockholders' deficit of $7,502,437.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.0—
Gross profit-0.0—
Profit before tax-1.2-1.5
Net income-1.2-1.5
EPS (diluted, $ a share)$-0.00$-0.00

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Gross margin-44.0%
Source

10-Q filed with the SEC, OTC: KBLB. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Kraig Biocraft Laboratories, Inc.: key numbers

Share price
$0.0805Close, Nov 17
Market cap
$88.5M
Shares outstanding
1.1BLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)SIC 2820

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.